CLEC4D as a Novel Prognostic Marker Boosts the Proliferation and Migration of Gastric Cancer via the NF-κB/AKT Signaling ...
Introduction The numbers of gastric cancer (GC) cases and related deaths have declined gradually over the past 5 decades, GC remains a global health burden, as it is the fifth most frequently diagnosed malignancy and the fourth leading cause of cancer- …